Ismael, Alfadz A.
HRN: 23-26-34 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/21/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/21/2023
07/28/2023
IV
160mg
Q8hrs
PCAP C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes